INTERNATIONAL PATENT: SHENTUO BIOTECHNOLOGY (HANGZHOU) CO., LTD., 神拓生物技术（杭州）有限公司 FILES APPLICATION FOR "LENTIVIRAL VECTOR FOR GENE THERAPY OF NEUROFIBROMATOSIS TYPE 2 AND USE THEREOF"

Posted On: 2025-09-08

GENEVA, Sept. 8 -- SHENTUO BIOTECHNOLOGY (HANGZHOU) CO., LTD. (Room 105, Floor 1, Building 18, Qianwan Bioport Phase I, Life Science and Technology Innovation CenterNo. 3300 Benjing Avenue, Ningwei Street, Xiaoshan District, (Self-declaration)Hangzhou, Zhejiang 311200), 神拓生物技术（杭州）有限公司 (中国浙江省杭州市萧山区宁围街道奔竞大道3300 号生命科学科创中心钱湾生物港一期18 幢1 层105 室(自主申报)) filed a pat...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SHENTUO BIOTECHNOLOGY (HANGZHOU) CO., LTD., 神拓生物技术（杭州）有限公司 FILES APPLICATION FOR "LENTIVIRAL VECTOR FOR GENE THERAPY OF NEUROFIBROMATOSIS TYPE 2 AND USE THEREOF"